09Feb 2025
Extra Rituximab Dose Lowers Pemphigus Relapse

Extra Rituximab Dose Lowers Pemphigus Relapse

A multicenter study in France evaluated 87 pemphigus patients treated with rituximab. At month 6, 30 of 77 in remission had relapse predictors and received an additional rituximab infusion. None relapsed, while 2 of 47 without predictors did, yielding a relapse rate of 2.6% and an NNT of 3.6. At month 12, 93.5% of those in remission at month 6 remained corticosteroid-free for ≥2 months.

  • #dermatology

Like

Save

Share